Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on April 24, 2008

Arteriosclerosis, Thrombosis, and Vascular Biology. 2008
Published online before print April 24, 2008, doi: 10.1161/ATVBAHA.108.162347
A more recent version of this article appeared on June 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
28/6/1111    most recent
ATVBAHA.108.162347v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dole, V. S.
Right arrow Articles by Krieger, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dole, V. S.
Right arrow Articles by Krieger, M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
Medline Plus Health Information
*Platelet Disorders

Submitted on January 7, 2008
Accepted on March 26, 2008

Thrombocytopenia and Platelet Abnormalities in High-Density Lipoprotein Receptor–Deficient Mice

Vandana S. Dole ; Jana Matuskova ; Eliza Vasile ; Ayce Yesilaltay ; Wolfgang Bergmeier ; Michael Bernimoulin ; Denisa D. Wagner ; and Monty Krieger *

From the Department of Biology (V.S.D., E.V., A.Y., M.K.), Massachusetts Institute of Technology, Cambridge; and Immune Disease Institute and Department of Pathology (J.M., W.B., M.B., D.D.W.), Harvard Medical School, Boston, Mass.

* To whom correspondence should be addressed. E-mail: Krieger{at}MIT.edu.

Objective—High-density lipoprotein (HDL) receptor, scavenger receptor class B, type I (SR-BI), mediated cellular uptake of lipoprotein cholesterol controls HDL structure and plasma HDL and biliary cholesterol levels. In SR-BI knockout (KO) mice, an unusually high plasma unesterified-to-total cholesterol ratio (UC:TC) and abnormally large HDL particles apparently contribute to pathology, including female infertility, susceptibility to atherosclerosis and coronary heart disease, and anemia. Here we examined the influence of SR-BI deficiency on platelets.

Methods and Results—The high plasma UC:TC ratio in SR-BI KO mice was correlated with platelet abnormalities, including high cholesterol content, abnormal morphologies, high clearance rates, and thrombocytopenia. One day after platelets from wild-type mice were infused into SR-BI KO mice, they exhibited abnormally high cholesterol content and clearance rates similar to those of endogenous platelets. Platelets from SR-BI KO mice exhibited in vitro a blunted aggregation response to the agonist ADP but a normal response to PAR4.

Conclusions—In SR-BI KO mice abnormal circulating lipoproteins, particularly their high UC:TC ratio—rather than the absence of SR-BI in platelets themselves—induce defects in platelet structure and clearance, together with a mild defect in function.


Key words: HDL receptor • SR-BI • platelet • thrombocytopenia • clearance